Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ABUSABUS
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ARBUTUS BIOPHARMA CORP

GOLDMAN SACHS GROUP INC holds 3.5M shares of ABUS (ARBUTUS BIOPHARMA CORP), worth $16.8M as of 2026-Q2. The position was increased (+218.7% shares). ABUS represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$16.8M

Current Shares

3.5M

Total Value Change

+$15.1M

Total Shares Change

+3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.5M
+218.7%
$16.8M0.0%$4.80
46
2026-Q1
Increased
1.1M
+49.0%
$5M0.0%$4.69
37
2025-Q4
Decreased
738,580
-66.0%
$3.6M0.0%$4.62
0
2025-Q3
Decreased
2.2M
-28.5%
$9.9M0.0%$4.46
0
2025-Q2
Increased
3M
+46.4%
$9.4M0.0%$3.13
38
2025-Q1
Increased
2.1M
+290.3%
$7.2M0.0%$3.50
44
2024-Q4
New
531,878
-
$1.7M0.0%$3.20
36

Other major holders of ABUS: MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used